IBD Stock Of The Day AstraZeneca Stalls As Gilead Looks To Take Its Breast Cancer Market

IBD Stock Of The Day AstraZeneca Stalls As Gilead Looks To Take Its Breast Cancer Market

AstraZeneca is the IBD Stock Of The Day amid growing enthusiasm for its cancer drug, Enhertu. But AZN stock hit resistance Monday.